Danielle Meijer
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Direct oral anticoagulant interference and removal in the factor VIII inhibitor assay.
Journal: Research and practice in thrombosis and haemostasis
Published: October 06, 2025
Impaired tolerance in the International Immune Tolerance Induction study due to the presence of very low-titer inhibitors.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 27, 2025
Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment.
Journal: Thrombosis research
Published: March 22, 2024
The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
Journal: Frontiers in immunology
Published: December 14, 2023
The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A.
Journal: Thrombosis research
Published: July 19, 2023
Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases.
Journal: Frontiers in cardiovascular medicine
Published: August 31, 2022
In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype.
Journal: Research and practice in thrombosis and haemostasis
Published: July 07, 2022
Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.
Journal: Research and practice in thrombosis and haemostasis
Published: November 09, 2021
ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin-6.
Journal: Research and practice in thrombosis and haemostasis
Published: September 09, 2021
Von Willebrand disease type 2M: Correlation between genotype and phenotype.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 21, 2021
A multi-center evaluation of TECHNOSCREEN® ADAMTS-13 activity assay as a screening tool for detecting deficiency of ADAMTS-13.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 26, 2019
Label-free LC-MSe in tissue and serum reveals protein networks underlying differences between benign and malignant serous ovarian tumors.
Journal: PloS one
Published: April 02, 2014
Last Updated: 09/26/2026